NCT07340606 The Role of the Pre-operative Condition and Artificial Intelligence-Assisted Diagnosis in Predicting the Success of Full Pulpotomy in Symptomatic Permanent Mature Molars
| NCT ID | NCT07340606 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Misr International University |
| Condition | Pulpitis - Irreversible |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2026-01-17 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2026-01-17 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effect of prognostic factors, such as the severity of pulpal inflammation, carious pulp exposure, and the presence of apical periodontitis, on the success of full pulpotomy in mature permanent molars with irreversible pulpitis. It also aims to investigate the role of artificial intelligence-assisted diagnosis in predicting the prognosis of full pulpotomy.
Eligibility Criteria
Inclusion Criteria: * Mature permanent molars with irreversible pulpitis. * Presence of bleeding from all canals. * The tooth is not periodontally compromised. Exclusion Criteria: * Non-vital teeth. * Uncontrolled bleeding from any of the canals after ten minutes of application of hemostatic agent. * Molars with immature roots.
Contact & Investigator
Ahmed M Ghobashy, Prof. Dr.
STUDY DIRECTOR
Misr International University
Frequently Asked Questions
Who can join the NCT07340606 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Pulpitis - Irreversible. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07340606 currently recruiting?
Yes, NCT07340606 is actively recruiting participants. Contact the research team at mayand.amer@miuegypt.edu.eg for enrollment information.
Where is the NCT07340606 trial being conducted?
This trial is being conducted at Cairo, Egypt, Cairo, Egypt.
Who is sponsoring the NCT07340606 clinical trial?
NCT07340606 is sponsored by Misr International University. The principal investigator is Ahmed M Ghobashy, Prof. Dr. at Misr International University. The trial plans to enroll 58 participants.